Cape Investment Advisory’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.2K Buy
+5,500
New +$20.1K 0.01% 690
2026
Q1
– Sell
-5,500
Closed -$37.2K – 791
2025
Q4
$37.2K Buy
+5,500
New +$38.5K 0.01% 485
2025
Q3
– Sell
-5,500
Closed -$33.6K – 1040
2025
Q2
$33.6K Hold
5,500
– – 0.01% 423
2025
Q1
$41.8K Hold
5,500
– – 0.02% 362
2024
Q4
$52.9K Hold
5,500
– – 0.02% 330
2024
Q3
$32.5K Hold
5,500
– – 0.01% 380
2024
Q2
$38.1K Hold
5,500
– – 0.02% 331
2024
Q1
$42.4K Hold
5,500
– – 0.02% 331
2023
Q4
$48.2K Buy
5,500
+500
+10% +$3.66K 0.02% 357
2023
Q3
$36.5K Hold
5,000
– – 0.02% 344
2023
Q2
$33K Buy
5,000
+1,000
+25% +$5.1K 0.02% 355
2023
Q1
$13.6K Buy
+4,000
New +$15.5K 0.01% 487

Other funds holding MDXG

Cape Investment Advisory's MDXG Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in MiMedx Group (MDXG) in Q2 2026: 5,500 shares worth $21.2K. The stake represents 0.01% of the portfolio and ranks #690 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in MDXG as recently as Q4 2025.

Cape Investment Advisory first reported a position in MDXG in Q1 2023 and has held it in 12 quarters since. The position peaked at $52.9K in Q4 2024. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Cape Investment Advisory held 5,500 shares of MiMedx Group worth $21.2K as of Q2 2026.
  • MiMedx Group was a new Cape Investment Advisory position in Q2 2026.
  • MiMedx Group made up 0.01% of Cape Investment Advisory's portfolio in Q2 2026, its #690 holding.
  • Cape Investment Advisory first reported a position in MiMedx Group in Q1 2023 and has held it in 12 quarters since.
  • Cape Investment Advisory's MiMedx Group position peaked at $52.9K in Q4 2024.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.